The company is selling its shares only through the offer-for-sale; there is no fresh issue in it. As per DRHP, in OFS up to 2.82 crore equity shares are sold by promoters and individual shareholders. Each share has a face value of ₹1. The entire fund will go to shareholders because the issue is entirely an OFS, and the company will not get any revenue from the IPO.
The book-running lead managers for the issue are Nomura Financial Advisory and Securities (India) Private Limited, J.P. Morgan India Private Limited, JM Financial Limited, Jefferies India Private Limited, and ICICI Securities Ltd.
The primary goal of the initial share sale is to maximize the benefits of listing equity shares on stock exchanges. The company also expects that listing the equity shares will increase liquidity for shareholders, visibility, and brand image, as well as create a public market for the equity shares.
The company provides technology-based healthcare solutions and a care-facilitating platform to physician enterprises in the United States, Canada, and Australia, with a primary focus on the US market. The company is designed to meet both outpatient and inpatient care needs. As of March 31, 2024, the company served 853 healthcare organizations based in the United States.
Aquity Holdings, a company that specializes in technology-based revenue integrity solutions, medical coding, and clinical documentation for the healthcare industry, was acquired by Inventurus Knowledge Solutions in 2023.
As of March 31, Inventurus Knowledge Solutions reported a net profit of Rs 370.4 crore. The company’s operations generated revenue of Rs 1,817 crore during the same period, as per DRHP.
